4//SEC Filing
Debrabandere Lode 4
Accession 0001179110-13-002638
CIK 0001360886other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:35 PM ET
Size
7.4 KB
Accession
0001179110-13-002638
Insider Transaction Report
Form 4
Debrabandere Lode
Vice President
Transactions
- Award
Incentive Stock Option (right to buy)
2013-02-12$7.73/sh+18,064$139,635→ 210,564 totalExercise: $7.73From: 2014-02-12Exp: 2023-02-12→ Common Stock (18,064 underlying) - Award
Non-Qualified Stock Option (right to buy)
2013-02-12$7.73/sh+11,936$92,265→ 222,500 totalExercise: $7.73From: 2014-02-12Exp: 2023-02-12→ Common Stock (11,936 underlying)
Footnotes (1)
- [F1]Options to purchase 30,000 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each Frebruary 12, 2014, 2015, 2016 and 2017, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.
Documents
Issuer
OSIRIS THERAPEUTICS, INC.
CIK 0001360886
Entity typeother
Related Parties
1- filerCIK 0001370936
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:35 PM ET
- Size
- 7.4 KB